All Articles

New research shows that cannabis works best as a treatment when interaction between all cannabinoids and terpenoids is allowed.

Patients suffer ‘Significantly Fewer Chronic Headaches After Taking Medical Marijuana.

A promising study has shown that medical marijuana can cut migraine frequency in half, offering hope for the millions who suffer from these severe, all-encompassing headaches.

In a policy brief published by the Medical Research Council on January 5, the medicinal value of cannabinoids was officially – and historically – recognised in South Africa. Three days later, the president signed into law the Medicines and Related Substances Amendment Act of 2015, a piece of legislation that theoretically allows Big Pharma to feed our dagga to us in pill form – or, if we like, through a straw. KEVIN BLOOM reports.

Type ‘CBD Oil’ into amazon.co.uk today and you will be met with nearly 200 results over 13 pages. The majority of these results will be for small quantities of oil obtained from industrial hemp, with a few waxes thrown in and even one seller offering 50g of hemp ‘bud’, supposedly for making tea with.

For many patients, ailments make inhalation or ingestion of medicinal cannabis impossible. Left without options, many have come up with their own way to benefit from the medical aspects of cannabis – by suppository.

New study from University of East Anglia reveals important details of marijuana’s ‘poorly understood’ anti-cancer properties.

No one wants their kids tripping out. That’s why many B.C. parents have in recent months formed a loose network, sharing tips on CBD dosage and which dispensaries offer the most suitable products for children, while they wait for science and law to catch up with demand.

Most people can recall a time they got way too high and experienced a bit of a paranoid episode. Sometimes it manifests as mild worrying, and other times you find yourself in the fetal position at the top of a Doritos pile dialing 911 because surely this high will be the death of you (true story, guys).

Medical marijuana shows promise for ailing companion animals.

Cannabidiol (CBD) has been the focus of many medical cannabis studies, and continues to prove itself as a powerful anti-inflammatory drug. What makes CBD even more desirable for some patients is that it does not cause the psychoactive effects associated with tetrahydrocannabinol (THC).

The ability of cannabis to improve the symptoms of glaucoma has been demonstrated in various studies, but doubts still remain over its efficacy and consistency within patient populations. Despite this, many medical cannabis patients utilize cannabis for glaucoma, and report subjective improvements in various symptoms.

Recent research has also found that our skin actually functions as a neuro-immuno-endocrine organ. More research needs to be done in order to learn about the many functions our skin performs, but it’s safe to say that it is very important, and whether our skin is normal or diseased, it should not be ignored.

Medical marijuana is far more effective at treating symptoms of fibromyalgia than any of the three prescription drugs approved by the Food and Drug Administration to treat the disorder.

Marijuana has been proven to be tremendously effective when it comes to treating epilepsy. It seems like most of the time that I see medical marijuana being talked about on the news or in print media, it’s almost always talking about how CBD can help epilepsy, with countless success stories.

Three studies presented at the American Epilepsy Society’s 69th Annual Meeting in Philadelphia Dec. 7th found a marijuana-derived extract slashed pediatric seizures in half, and completely stopped seizures in nine percent of cases.

Over the past few years, research has revealed that marijuana can both destroy certain cancer cells and reduce the growth of others. Now, a new study in mice has found that when combined with radiation treatment, cannabis can effectively shrink one of the most aggressive types of brain tumors.

A European based pharmaceutical company called GW Pharmaceuticals is set to commence its first phase of clinical trials for the treatment of Glioblastoma Multiforme (GBM). It’s a bio-pharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform.

The science supporting the use of cannabis for Multiple Sclerosis (MS) is absolutely compelling.

"Marijuana, in it’s natural form, is one of the safest therapeutically active substances known to man … One must reasonably conclude that there is accepted safety for use of marijuana under medical supervision. To conclude otherwise, on the record, would be unreasonable, arbitrary, and capricious"  – DEA Administrative Law Judge Francis J. young, 1988